Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saffron in mild to moderate Alzheimer's disease
IRCT138711051556N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saffron extract in Alzheimer's disease (AD), sponsored by Tehran University of Medical Sciences. Started Nov 2006; status: completed.
02
Drugs
saffron extract
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on IRCT138711051556N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138711051556N1.